ModuLight.bio Ltd.
Biomed — Stage: R&D. Est: 2022. Tags: Artificial Intelligence, BrainTech, Genetics, Life Sciences, MedTech. ModuLight.bio develops treatments within healthcare and biotechnology. The company includes treatments for severe neurological syndromes such as drug-resistant focal epilepsy, Parkinson's and severe neuropathic pain, utilizing groundbreaking deep technology. The company's services primarily cater to the healthcare industry.. Web: https://modulight.bio